The same protein expression pattern was observed in human SCLC cells treated with dinaciclib, including downregulation of BCL-xL and increased levels of cleaved Caspase-3 and PARP, indicating activation of apoptosis upon treatment (Fig. 1E). This evidence concerns the gene BCL2L1 and small cell lung carcinoma.